Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Recent patent literature reports new therapeutic agents insomnia, anxiety, etc.

Nov. 28, 2006

NDA filed for Zingo needle-free local anesthetic

Nov. 28, 2006

Plans for clinical investigation of low-dose cortisol for chronic PTSD

Nov. 28, 2006

New patents report agents for treating neurological disorders

Nov. 27, 2006

Enrollment open in relapsing remitting MS study of MBP-8298

Nov. 27, 2006

Betaferon approved in Australia for earliest stages of MS

Nov. 24, 2006

ExonHit identifies companion diagnostic to assist EHT-0202 development

Nov. 24, 2006

Recent Vertex and Pfizer patents report novel analgesic agents

Nov. 23, 2006

Keppra recommended in E.U. for new epilepsy indication

Nov. 23, 2006

Clearance for first clinical study of BF-1 for prophylaxis of severe migraine

Nov. 23, 2006

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...